CompletedNCT01376622
Changes in Pituitary Iron and Volume With Deferasirox
Studying Rare hereditary hemochromatosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Children's Hospital Los Angeles
- Principal Investigator
- John C Wood, MD, PhDChildren's Hospital Los Angeles
- Enrollment
- 130 target
- Eligibility
- 2-25 years · All sexes
- Timeline
- 2008 – 2011
Study locations (1)
- Children's Hospital Los Angeles, Los Angeles, California, United States
Collaborators
Novartis Pharmaceuticals
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01376622 on ClinicalTrials.govOther trials for Rare hereditary hemochromatosis
Additional recruiting or active studies for the same condition.